Trump says tariffs will accelerate reshoring, but experts say it’s not that easy

Arseniy45 | Istock | Getty ImagesPresident Donald Trump may hope his tariffs jump-start a renaissance in manufacturing in the United States, but the reality is not so simple, according to experts.The president announced sweeping tariffs Wednesday, including a baseline 10% levy across the board on all imports. He also...

Read more...

U.S. households are running out of emergency funds as pandemic cash runs out, inflation takes its toll

Vithun Khamsong | Moment | Getty ImagesIt is becoming harder for Americans to come up with money in case of an emergency, according to a recent survey from the New York Federal Reserve.The bank's Survey of Consumer Expectations for February found that the average likelihood of Americans being able...

Read more...

X, T, SYF, CVS and more

Check out the companies making the biggest moves in premarket trading: U.S. Steel — Shares tumbled 7% after President-elect Donald Trump said late Monday he will block the purchase of the steelmaker by Japan's Nippon Steel. A deal was reached in late 2023 for Nippon Steel to buy U.S....

Read more...

NVDA, TRV, BX and UBER

Check out the companies making the biggest moves midday: Taiwan Semiconductor — Shares surged 12% after the company, which is the world's largest producer of advanced chips, reported a 54% gain in net profit for the third quarter driven by strong AI-related demand. Shares of chip giants Nvidia and...

Read more...

BA, DELL, MRK and more

Check out the companies making the biggest moves in premarket trading: Boeing — Shares jumped 4% after the aircraft maker reached a deal with a union that represents its factory workers, potentially avoiding a costly strike. MarineMax — Shares jumped 6% after Citi upgraded shares to buy from neutral....

Read more...

LLLY, PARA, HA, PANW and more

Check out the companies making the biggest moves in premarket trading: Eli Lilly — Shares added 1.7% after a late-stage trial found the pharma company's weight-loss drug tirzepatide, the active ingredient Zepbound and Mounjaro, reduced the risk of obese or overweight adults developing Type 2 diabetes by 94%. Paramount...

Read more...